Phase 1 Study of Sipuleucel-T and Ipilimumab in Combination for Advanced Prostate Cancer
Phase of Trial: Phase I
Latest Information Update: 30 Aug 2017
At a glance
- Drugs Ipilimumab (Primary) ; Sipuleucel-T (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics
- 23 Aug 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.